Cargando…
Statin use, hyperlipidaemia, and the risk of breast cancer
Hydroxymethyl glutaryl coenzyme A inhibitors (‘statins’) are carcinogenic in rodents and an increased incidence of breast cancer was reported among pravastatin users in one randomised trial. We conducted a case–control study in the General Practice Research Database to evaluate the risk of breast ca...
Autores principales: | Kaye, J A, Meier, C R, Walker, A M, Jick, H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375376/ https://www.ncbi.nlm.nih.gov/pubmed/11986777 http://dx.doi.org/10.1038/sj.bjc.6600267 |
Ejemplares similares
-
Statin use and cancer risk in the General Practice Research Database
por: Kaye, J A, et al.
Publicado: (2004) -
Statin use and risk of liver cancer: an update meta-analysis
por: Shi, Meng, et al.
Publicado: (2014) -
Screening for Hyperlipidaemia in Childhood: Recommendations of the British Hyperlipidaemia Association
por: Wray, R, et al.
Publicado: (1996) -
Epidemiology of basal cell carcinoma in the United Kingdom: incidence, lifestyle factors, and comorbidities
por: Reinau, D, et al.
Publicado: (2014) -
Statin use is not associated with reduced risk of skin cancer: a meta-analysis
por: Li, X, et al.
Publicado: (2014)